Carlsberg India, TMC Transformers, Ujin Pharma, and Matangi Rubber have received approval from the Securities and Exchange Board of India (SEBI) to launch their initial public offerings (IPOs). This approval allows these companies to raise funds from the public through share sales.
- Carlsberg India will launch an offer-for-sale IPO without fresh shares.
- TMC Transformers plans a ₹550 crore IPO with fresh equity issuance.
- Ujin Pharma’s IPO combines fresh shares and offer-for-sale by promoters.
- Matangi Rubber’s IPO includes fresh issuance and offer-for-sale shares.
What companies received SEBI approval for IPOs?
Four companies have recently received SEBI’s go-ahead to launch their IPOs: Carlsberg India Ltd, TMC Transformers (India) Ltd, Ujin Pharma, and Matangi Rubber. These companies had submitted their draft red herring prospectuses (DRHPs) between May and July 2026 and obtained SEBI’s observations between September 28 and October 1, 2026.
What is the significance of SEBI's observation?
In SEBI’s process, receiving an observation means the regulator has reviewed the IPO proposal and given permission to proceed with the public offering. This is a crucial step before companies can officially launch their share sales to investors.
What details are known about Carlsberg India’s IPO?
Carlsberg India, the Indian subsidiary of the Danish Carlsberg Group, filed confidential preliminary papers with SEBI on July 1, 2026. Their IPO will be an offer-for-sale (OFS) only, meaning no new shares will be issued. This move allows Carlsberg to tap into India’s equity markets, joining other multinational firms like Hyundai Motor and LG Electronics that have listed their Indian units.
How will TMC Transformers use the IPO funds?
TMC Transformers plans to raise ₹550 crore through a fresh issuance of equity shares. The funds will support capital expenditure for setting up a new Extra High Voltage (EHV) transformer manufacturing unit, meet incremental working capital needs, and cover general corporate purposes.
What is included in Ujin Pharma’s IPO?
Ujin Pharma’s IPO consists of a fresh issuance of 1.18 crore shares and an offer-for-sale of 72.82 lakh shares by promoters Umang Ketan Mehta and Jinesh Rasiklal Sheth. The company plans to invest ₹61.7 crore in Altra Agro-Chem and ₹21.6 crore in Altra Pharma-Chem, making them subsidiaries. Additionally, ₹25 crore will be used to clear debt, with the remainder allocated for general corporate needs.
What are the details of Matangi Rubber’s IPO?
Matangi Rubber’s IPO includes a fresh issuance of 57,61,831 shares and an offer-for-sale of 15,15,150 shares by promoters and existing investors. The raised funds will be used to repay debt, finance capital expenditure, and support general corporate purposes.
Are there other companies planning IPOs?
Yes, at least 16 other companies have filed their DRHPs with SEBI. These include firms from various sectors such as real estate, renewable energy, manufacturing, and jewelry. Some of these companies are Anarock Property Consultants, BS Sponge, Inox Air Products, Grace Renewable Energy, and Dosti Realty.
These IPOs reflect growing interest among Indian and multinational companies to raise capital through public markets to fund expansion and strengthen their financial positions.
